365 related articles for article (PubMed ID: 1988490)
1. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
[TBL] [Abstract][Full Text] [Related]
2. Active and passive immunization against Plasmodium yoelii sporozoites.
Charoenvit Y; Sedegah M; Yuan LF; Gross M; Cole C; Bechara R; Leef MF; Robey FA; Lowell GH; Beaudoin RL
Bull World Health Organ; 1990; 68 Suppl(Suppl):26-32. PubMed ID: 1709834
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites.
Ak M; Bower JH; Hoffman SL; Sedegah M; Lees A; Carter M; Beaudoin RL; Charoenvit Y
Infect Immun; 1993 Jun; 61(6):2493-7. PubMed ID: 8500885
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites.
Mellouk S; Berbiguier N; Druilhe P; Sedegah M; Galey B; Yuan L; Leef M; Charoenvit Y; Paul C; Hoffman S
Bull World Health Organ; 1990; 68 Suppl(Suppl):52-9. PubMed ID: 2094592
[TBL] [Abstract][Full Text] [Related]
5. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene.
Sedegah M; Beaudoin RL; Majarian WR; Cochran MD; Chiang CH; Sadoff J; Aggarwal A; Charoenvit Y; Hoffman SL
Bull World Health Organ; 1990; 68 Suppl(Suppl):109-14. PubMed ID: 2094576
[TBL] [Abstract][Full Text] [Related]
7. Towards the design of heterovalent anti-malaria vaccines: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of the malaria parasite, Plasmodium.
Kironde FA; Rao KV; Shah S; Kumar A; Sahoo N
Immunology; 1991 Oct; 74(2):323-8. PubMed ID: 1721043
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
[TBL] [Abstract][Full Text] [Related]
10. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
[TBL] [Abstract][Full Text] [Related]
11. Immunization with hybrid hepatitis B virus core particles carrying circumsporozoite antigen epitopes protects mice against Plasmodium yoelii challenge.
Schödel F; Peterson D; Milich DR; Charoenvit Y; Sadoff J; Wirtz R
Behring Inst Mitt; 1997 Feb; (98):114-9. PubMed ID: 9382731
[TBL] [Abstract][Full Text] [Related]
12. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
Rotman HL; Daly TM; Clynes R; Long CA
J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
[TBL] [Abstract][Full Text] [Related]
13. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
14. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
Majarian WR; Daly TM; Weidanz WP; Long CA
J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
[TBL] [Abstract][Full Text] [Related]
15. The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.
Chattopadhyay R; Conteh S; Li M; James ER; Epstein JE; Hoffman SL
Vaccine; 2009 Jun; 27(27):3675-80. PubMed ID: 19071177
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
17. The role of CD4+ T cells in immunity to malaria sporozoites.
Weiss WR; Sedegah M; Berzofsky JA; Hoffman SL
J Immunol; 1993 Sep; 151(5):2690-8. PubMed ID: 8103069
[TBL] [Abstract][Full Text] [Related]
18. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
19. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
Yuan J; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
[TBL] [Abstract][Full Text] [Related]
20. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]